Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-11-024911
Filing Date
2011-03-14
Accepted
2011-03-11 18:45:50
Documents
1
Period of Report
2011-04-19
Effectiveness Date
2011-03-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A g26447def14a.htm DEF 14A 348774
  Complete submission text file 0000950123-11-024911.txt   349783
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33637 | Film No.: 11683540
SIC: 2834 Pharmaceutical Preparations